An investment frenzy over “generative artificial intelligence” has gripped Silicon Valley, as tools that generate text, images and sounds in response to short prompts seize the imagination. » mehr lesen
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other...
Federal Reserve officials, including Lisa Cook, a board member, are wrestling with how to think about price increases after 18 months of rapid change. » mehr lesen
In a call with investors on Thursday, the chief financial officer of Walgreens, James Kehoe, said “maybe we cried too much last year” over theft. » mehr lesen